HPGDS and acute kidney injury: In addition to these well-established biomarkers, new biomarkers for cisplatin-mediated AKI have recently been reported (α-glutathione-S-transferase for proximal tubular injury, μ-glutathione-S-transferase for distal tubular injury, renal papillary antigen-1 for collecting duct injury, and clusterin for general kidney injury) [81].